We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Abingdon Health Plc | LSE:ABDX | London | Ordinary Share | GB00BLF79J41 | ORD 0.025P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.15 | -1.6% | 9.25 | 175,150 | 11:51:25 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 9.00 | 9.50 | 9.40 | 9.25 | 9.40 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | 4.05M | -3.45M | -0.0114 | -8.11 | 28.12M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 13:31:25 | O | 15,796 | 9.075 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/11/2023 | 07:00 | UKREG | Abingdon Health PLC Notice of Annual General Meeting |
| 25/10/2023 | 06:00 | UKREG | Abingdon Health PLC Director/PDMR Shareholding |
| 24/10/2023 | 12:26 | ALNC |  Abingdon Health appoints Feather as new interim finance director |
| 24/10/2023 | 06:05 | UKREG | Abingdon Health PLC Award of Options under LTIP |
| 18/10/2023 | 09:22 | ALNC | IN BRIEF: Abingdon Health finance chief resigns, seeks interim hire |
| 18/10/2023 | 06:00 | UKREG | Abingdon Health PLC Directorate Change |
| 17/10/2023 | 10:06 | ALNC | Abingdon Health reports narrowed annual loss as shifts away from Covid |
| 17/10/2023 | 06:00 | UKREG | Abingdon Health PLC Final Results |
| 11/10/2023 | 06:00 | UKREG | Abingdon Health PLC Notice of Results |
| 07/9/2023 | 06:41 | ALNC | *Abingdon Health & Morrama will invest in Eco-Flo to develop sustainable.. |
Abingdon Health (ABDX) Share Charts1 Year Abingdon Health Chart |
|
1 Month Abingdon Health Chart |
Intraday Abingdon Health Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 16/10/2023 | 10:44 | Abingdon Health: Lateral Flow Diagnostics | 1,574 |
| 21/12/2022 | 15:52 | freeFor all rampngFree | 69 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 13:31:26 | 9.08 | 15,796 | 1,433.49 | O |
| 12:10:11 | 9.40 | 15,000 | 1,410.00 | O |
| 12:08:09 | 9.41 | 10,548 | 992.04 | O |
| 11:51:27 | 9.08 | 8,888 | 806.59 | O |
| 11:51:25 | 9.00 | 30 | 2.70 | O |
| Top Posts |
|---|
Posted at 04/12/2023 08:20 by Abingdon Health Daily Update Abingdon Health Plc is listed in the Chemicals & Chem Preps, Nec sector of the London Stock Exchange with ticker ABDX. The last closing price for Abingdon Health was 9.40p.Abingdon Health currently has 304,033,634 shares in issue. The market capitalisation of Abingdon Health is £28,123,111. Abingdon Health has a price to earnings ratio (PE ratio) of -8.11. This morning ABDX shares opened at 9.40p |
Posted at 14/10/2023 13:42 by timbo003 Register for the seminar mentioned in the previous post (which includes a presentation from ABDX) here: |
Posted at 14/10/2023 10:45 by sharesoc ShareSoc is holding its first hybrid event in London on 19th Oct. Hear from Abingdon Health (ABDX) and other healthcare companies like Tristel Plc (TSTL), Inspiration Healthcare Group (IHC), Creo Medical Group (CREO) and GENincode (GENI). Attend in-person or online.📍 |
Posted at 28/6/2023 21:53 by criticalthinker1 Had to pay my road tax today. Long story short. So ventured into a smaller Superdrug outlet. No Salistick on display. The representative said that she knew of them and they were being supplied to the larger shops first and the smaller ones later. A recent delivery was awaiting shop distribution of latest delivery ...are we there?...That's a distribution factor I suppose. Anyways. Ongoing. Spit or pee? That is the question! And the price point is well within the parameters of the markets. One of the clear blue 29.99. Check it out for yourself. Even if you identify as a potato you can check out if you are impregnated by a mouth swab as opposed to a urinal splatter test. |
Posted at 12/6/2023 21:23 by red army Although I can't disagree. There is a lot of promise in the price with a market cap of £36m and tomorrow probably £40m. My short term strategy is buy on rumour a couple of months ago and take profit on news. |
Posted at 12/6/2023 20:23 by criticalthinker1 I'm guessing that is to sell a tranche of your shares?.....always good to take a cut...but I'm holding and adding.Your next target would be a 15% rise on today's rise, but depending on the spread that the brokers decide on due to volume (buys and sells), so about half today's rise. But depending when you bought. My opinion fwiw....and note I raise the Novacyt point...and note how since our listing (note the price then to now and since then the increased ipr/licenses and market awareness) we have been exonerated of any profiteering or wrongdoing re the 'covid' debacle of testing et al! And one of our NEOs has a significant holding with no intention to sell and put some 3m in trust. This company has the values I look for, not many out there. Leadership, vision, ongoing licensing, ipr updates re the smartphone feature, board investment, a couple other products aside from Salistick that I think will have there moment recognised... The MHRA has caused disruption to UK drug/supporting paraphernalia products and the vast economy they support, with poor excuses. Emma Walmsley has also said such. Bandits imo. So given my cynical view of the financial world and the strings they hold, I think we have paid our dues re negative media and I'd say I'm looking at the next target to be just over 20p within 2 weeks, assuming Salistick product launch and then that garnering Abingdon market awareness, and Mr Yates purchase at 25p. Then maybe a short (profit taking) breather, down to about 16p then up to.....well 25p and then £s. All best. This is my opinion and my hope! |
Posted at 12/6/2023 19:07 by criticalthinker1 Buckled in. Seen this price type graph (last 6 months) before. Imo its about fundamentals being seen early by some who can see the mc value potential, so they buy and hold. Some think they get it so buy early ish and sell, probably at last little 'peak', thinking mc value reached.Each to their own. So they sell and share price goes down, but the floor is going up and up. Reminds me of the Novacyt days. Note Novacyts test was a 'period' of making hay whilst the 'pandemic' was, well actually an epidemic from the early days, and that's fact. This has got legs. And not just a one trick pony... Salistik is a game changer imo. This product unless superceded by a better product is going to own the pregnancy test market for a considerable time! Globally? Well atleast we got the rights to the UK and Ireland. It's also worth noting that we are entering the period of increased pregnancies in certain places due to increased testosterone due to sunshine. So the product release date (got to be imminent) is going to see a sustained increase in sales. Not sure if the marketing department has done this by design or accident, but as long as the product is readily available...hold onto your hats! |
Posted at 11/4/2023 09:13 by mrmark1 In production now and launching in May with a big advertising campaign. Amazon and other sites/stores with co-branded products. ABDX is the exclusive sole manufacturer and distributor for the worlds first saliva pregnancy test for the UK. |
Posted at 28/1/2023 16:14 by shallow pockets We have exited this stock at several long held targeted prices on our short positions, rhe last price being 4p, and witnessed the death of all bulls.But we retain a morbid fascination in watching a duck actually die. There will be several death rattles here, we suspect, before this particular duck dies, as predators look it over, thinking it may be cheap and of value. But a quick look over the "assets" (dwindling cash and a few bits of kit not worth much in the 2nd hand market...and nothing else) along with a disastrous incumbent management team and board who talk nonsense and have grossly overpaid themselves, and possible buyers walk quickly away. So see these mini bounces of rumoured acquisitions for what they are....false hope because dont doubt it, this duck dies. But watching its death is curiously interesting. |
Posted at 20/9/2022 07:54 by shallow pockets It's going to get a little neurotic for those still in this stock as we head to 4p. The likes of Bigjock36 shouldn't get any hopes up though, when a price spike occurs. There will be some flies buzzing around the carcass of this management destroyed company from time to time seeking to buy the company as the share price sinks lower, thinking it looks cheap and that the book value outweighs the share price, until they realise in DD that there are no proper assets other than cash, which is dwindling heavily by the day, mostly to overpay the Board,, and that the share price, far from being cheap now, was just ridiculously expensive previously, with the Board clueless and unable to grab the once in a lifetime opportunity that was infront of it. Show us their qualifications to ever have done so.Its a shame that Bigjock36 and his fellow bulls didn't make this analysis much earlier before they lost all of their investment. Stay short. Target 4p. |
Posted at 06/4/2022 12:24 by bobdown2 A very large sell followed by 2 small buys and the share price is in the top half of the spread. I suggest you look at todays trades to see how a sellers position unwinds.I need 12 pence to be in profit.i have made four trades in three or four days. And today the markets found out that abdx is still working with avacta. A payment from the DHSC could double the share price at these levels. But I think they are drawing the process out to lower the settlement. Still contracts look to be arriving and abdx look to have come through the mess. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
